東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Drug treatment of sleep disorders

Guglietta, Antonio.

Linked to FindBook

Google Book

Amazon

博客來

Drug treatment of sleep disorders

Record Type:	Electronic resources : Monograph/item
Title/Author:	Drug treatment of sleep disorders/ edited by Antonio Guglietta.
other author:	Guglietta, Antonio.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	viii, 297 p. :ill., digital ;24 cm.
[NT 15003449]:	An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
Contained By:	Springer eBooks
Subject:	Sleep disorders - Chemotherapy. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-11514-6
ISBN:	9783319115146 (electronic bk.)

Drug treatment of sleep disorders
Drug treatment of sleep disorders[electronic resource] /edited by Antonio Guglietta. - Cham :Springer International Publishing :2015. - viii, 297 p. :ill., digital ;24 cm. - Milestones in drug therapy,2296-6056. - Milestones in drug therapy..

An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

ISBN: 9783319115146 (electronic bk.)

Standard No.: 10.1007/978-3-319-11514-6doiSubjects--Topical Terms:

2131524
Sleep disorders
--Chemotherapy.

LC Class. No.: RC547

Dewey Class. No.: 616.8498061

Drug treatment of sleep disorders
LDR:02588nmm a2200325 a 4500 001 1993350
003 DE-He213
005 20150629165837.0
006 m d
007 cr nn 008maaau
008 151019s2015 gw s 0 eng d
020 $a 9783319115146 (electronic bk.)
020 $a 9783319115139 (paper)
024 7 $a 10.1007/978-3-319-11514-6 $2 doi
035 $a 978-3-319-11514-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC547
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 616.8498061 $2 23
090 $a RC547 $b .D794 2015
245 0 0 $a Drug treatment of sleep disorders $h [electronic resource] / $c edited by Antonio Guglietta.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a viii, 297 p. : $b ill., digital ; $c 24 cm.
490 1 $a Milestones in drug therapy, $x 2296-6056
505 0 $a An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
520 $a Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.
650 0 $a Sleep disorders $x Chemotherapy. $3 2131524
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Neurosciences. $3 588700
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Psychopharmacology. $3 568143
700 1 $a Guglietta, Antonio. $3 2131523
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Milestones in drug therapy. $3 1565346
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-11514-6
950 $a Biomedical and Life Sciences (Springer-11642)